Despite significant advancements in medical imaging and artificial intelligence, tissue biopsy remains a necessary component for definitive cancer diagnosis and staging.
The retrieved literature consistently supports the position that while advanced imaging (such as mpMRI, CT, and radiomics) has improved localization and characterization, definitive cancer diagnosis and staging still heavily rely on pathological confirmation via tissue or liquid biopsy due to imaging limitations in sensitivity and specificity.